Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Concord Drugs Ltd.
Swot
Concord Drugs Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Concord Drugs Ltd. has 6 Strengths, 6 Weaknesses, 0 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(6)
Weakness
(6)
Opportunity
(0)
Threats
(0)
Others
(3)
Growth in Net Profit with increasing Profit Margin (QoQ)
Company with Low Debt
Increasing profits every quarter for the past 3 quarters
Company with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Top Gainers
Companies with growing costs YoY for long term projects
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Weak Momentum: Price below Short, Medium and Long Term Averages
Stocks Underperforming their Industry Price Change in the Quarter
Bullish or Bearish Candlestick Strength - Indices
Bullish Harami (Bullish Reversal)
Decline in Quarterly Net Profit with falling Profit Margin (YoY)
